Display Settings:

Format

Send to:

Choose Destination
    Neurobiol Dis. 2010 Nov;40(2):432-43. Epub 2010 Jul 14.

    Aspartoacylase deficiency affects early postnatal development of oligodendrocytes and myelination.

    Source

    Department of Neurobiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.

    Abstract

    Canavan disease (CD) is a neurodegenerative disease, caused by a deficiency in the enzyme aspartoacylase (ASPA). This enzyme has been localized to oligodendrocytes; however, it is still undefined how ASPA deficiency affects oligodendrocyte development. In normal mice the pattern of ASPA expression coincides with oligodendrocyte maturation. Therefore, postnatal oligodendrocyte maturation was analyzed in ASPA-deficient mice (CD mice). Early in development, CD mice brains showed decreased expression of neural cell markers that was later compensated. In addition, the levels of myelin proteins were decreased along with abnormal myelination in CD mice compared to wild-type (WT). These defects were associated with increased global levels of acetylated histone H3, decreased chromatin compaction and increased GFAP protein, a marker for astrogliosis. Together, these findings strongly suggest that, early in postnatal development, ASPA deficiency affects oligodendrocyte maturation and myelination.

    Copyright © 2010. Published by Elsevier Inc.

    PMID:
    20637282
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2964840
    Free PMC Article

    Images from this publication.See all images (8) Free text

    Fig. 1
    Fig. 3
    Fig. 5
    Fig. 7
    Fig. 2
    Fig. 4
    Fig. 6
    Fig. 8

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk